The AMPK pathway has been reported to control c-Myc expression through inhibition of the mTOR pathway in some cancer cells, including pancreatic neuroendocrine tumor cells, glioblastomas and leukemias [70,71,72,73]. The gene discussed is MTOR; the disease is cancer.